Your browser doesn't support javascript.
loading
Differential Proteomic Analysis of Hepatocellular Carcinomas from Ppp2r5d Knockout Mice and Normal (Knockout) Livers.
Lambrecht, Caroline; Ferreira, Gabriela Bomfim; Omella, Judit DomÈnech; Libbrecht, Louis; DE Vos, Rita; Derua, Rita; Mathieu, Chantal; Overbergh, Lut; Waelkens, Etienne; Janssens, Veerle.
Afiliação
  • Lambrecht C; Laboratory of Protein Phosphorylation and Proteomics, Department Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium.
  • Ferreira GB; Clinical and Experimental Endocrinology, Department Clinical and Experimental Medicine, University of Leuven (KU Leuven), Leuven, Belgium.
  • Omella JD; Laboratory of Protein Phosphorylation and Proteomics, Department Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium.
  • Libbrecht L; Department of Pathology, Université Catholique de Louvain (UCL), Brussels, Belgium.
  • DE Vos R; Translational Cell and Tissue Research, Department Imaging and Pathology, University of Leuven (KU Leuven), Leuven, Belgium.
  • Derua R; Laboratory of Protein Phosphorylation and Proteomics, Department Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium.
  • Mathieu C; Clinical and Experimental Endocrinology, Department Clinical and Experimental Medicine, University of Leuven (KU Leuven), Leuven, Belgium.
  • Overbergh L; Clinical and Experimental Endocrinology, Department Clinical and Experimental Medicine, University of Leuven (KU Leuven), Leuven, Belgium.
  • Waelkens E; Laboratory of Protein Phosphorylation and Proteomics, Department Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium Veerle.janssens@kuleuven.be Etienne.waelkens@kuleuven.be.
  • Janssens V; Laboratory of Protein Phosphorylation and Proteomics, Department Cellular and Molecular Medicine, University of Leuven (KU Leuven), Leuven, Belgium Veerle.janssens@kuleuven.be Etienne.waelkens@kuleuven.be.
Cancer Genomics Proteomics ; 17(6): 669-685, 2020.
Article em En | MEDLINE | ID: mdl-33099469
ABSTRACT

BACKGROUND:

Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. Mice lacking the tumor-suppressive protein phosphatase 2A subunit B56δ (Ppp2r5d) spontaneously develop HCC, correlating with increased c-MYC oncogenicity. MATERIALS AND

METHODS:

We used two-dimensional difference gel electrophoresis-coupled matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to identify differential proteomes of livers from wild-type, non-cancerous and HCC-affected B56δ knockout mice.

RESULTS:

A total of 23 proteins were differentially expressed/regulated in liver between wild-type and non-cancerous knockout mice, and 119 between non-cancerous and HCC knockout mice ('cancer proteins'). Overlap with our reported differential transcriptome data was poor. Overall, 56% of cancer proteins were reported before in HCC proteomics studies; 44% were novel. Gene Ontology analysis revealed cancer proteins mainly associated with liver metabolism (18%) and mitochondria (15%). Ingenuity Pathway Analysis identified 'cancer' and 'gastrointestinal disease' as top hits.

CONCLUSION:

We identified several proteins for further exploration as novel potential HCC biomarkers, and independently underscored the relevance of Ppp2r5d knockout mice as a valuable hepatocarcinogenesis model.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Proteoma / Proteína Fosfatase 2 / Neoplasias Hepáticas Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Carcinoma Hepatocelular / Proteoma / Proteína Fosfatase 2 / Neoplasias Hepáticas Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article